KOSECOFF JACQUELINE B

October 14, 2026

TriNet Expands Embedded HR Solutions and AI for SMBs. TriNet announced it is adding embedded HR solutions and new AI features aimed at small and medium‑sized businesses. The move broadens the company’s product lineup and could help it capture more of the growing HR‑tech market. The update comes as the stock trades near its 52‑week high and around key support levels.

October 11, 2026

ALHC Faces Downgrade and Lower Target Amid Mixed CMS Ratings. Alignment Healthcare shares are trading lower after William Blair downgraded the stock to Market Perform and JP Morgan cut its price target to $10. These moves followed mixed California Star Ratings and news of network expansion, which analysts say highlight ongoing operational challenges. The stock is currently trading near its 52-week low, reflecting the negative sentiment from these recent analyst actions.

October 5, 2026

Houlihan Lokey adds senior hires to financial services and fintech. Houlihan Lokey has strengthened its financial services group with a new senior hire and bolstered its fintech division by bringing in a digital assets specialist. These moves suggest the firm is focusing on expanding its capabilities in high-growth fintech and digital asset sectors. The stock is currently trading near its support level, reflecting a period of consolidation following recent price declines.

October 17, 2026

STERIS (STE) to acquire Xodus Medical for $2.1B. STERIS announced a definitive agreement to acquire Xodus Medical for about $2.1 billion. The deal adds a specialty surgical products business focused on patient and operating‑room staff safety, expanding STE’s consumables portfolio. The acquisition aligns with the company’s strategy to grow its healthcare offerings.

September 7, 2026

GoodRx Expands Savings Offering With Companion Family Plan for Pets and People. GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.